ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666355 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666355; 2) Community: the network communities that were significantly associated with the response to NSC 666355; 3) Molecule: the relationships between components within communities and NSC 666355; 4) MDR: the compounds that were significantly associated with the NSC 666355.

NSC Compound Enrichment Correlation
NSC 693867 Null 0.0385613993886001 -0.17689209
NSC 694620 Null 0.0385613993886001 0.36433706
NSC 697504 Null 0.0385613993886001 -0.24550159
NSC 699145 Null 0.0385613993886001 -0.11839655
NSC 705870 Null 0.0385613993886001 -0.25756357
NSC 713759 Null 0.0385613993886001 -0.27343616
NSC 718370 Null 0.0385613993886001 0.10274015
NSC 724781 (1S,4R,5R,8R,12R,13S)-9-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl -10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10.3.1. 04,13.08,13]hexadec-9-en-9-yl]methoxy}-2-butenyl)oxy]methyl} -1,5-dimethyl-10 0.0385613993886001 -0.3143135
NSC 727086 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-3a-pyrrolidino-5-androsten-17a-yl acetate 0.0385613993886001 -0.30347457
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.0385613993886001 -0.057828473
Total:71  Current:53    [First] [Prev] [Next] [Last]